Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Maker and taker fees vary by exchange. This guide compares the lowest current rates so you can minimize costs while maintaining liquidity and reliability.
26,847 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
As butterfly (BFLY) prepares for 2025 earnings, investors want clarity on growth, margins, and cash runway. This arti...
A fresh energy shock amid tariff tensions is tightening corporate margins. Markets moved lower as oil surged and poli...
Sea Limited entertained investors with strong earnings yet faced a dramatic intraday drop driven by rising fintech co...
President Trump ousted Homeland Security Secretary Kristi Noem on Thursday, signaling a rapid leadership shift and na...
A senior Pentagon official describes a turning point when DoD leaders realized their reliance on a single AI provider...
Global markets surged after President Trump hinted at de-escalation in Iran, easing oil risks and boosting equities. ...
AeroVironment shares extended a slide after the Space Force signaled a SCAR recompete and a stop-work order. We analy...
Early 2026 data shows SCHD pulling ahead of VYM and DGRO in total return and dividend growth, signaling a potential s...
Markets toppled and surged in swings as investors assessed a policy path that some say appears improvised. Analysts w...
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
A seasoned CEO message can move markets, especially in AI era. This deep dive explains what broadcom hock just delive...